IL86334A - Pharmaceutical compositions for transdermal delivery of a pure enantiomer - Google Patents

Pharmaceutical compositions for transdermal delivery of a pure enantiomer

Info

Publication number: IL86334A
Authority: IL; Israel
Prior art keywords: transdermal delivery; pharmaceutical compositions; pure enantiomer; enantiomers; compositions
Prior art date: 1987-06-12

Application number

IL86334A

Other languages

English (en)

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-12

Filing date

1988-05-11

Publication date

1992-09-06

1988-05-11 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1992-09-06 Publication of IL86334A publication Critical patent/IL86334A/xx

Links

230000037317 transdermal delivery Effects 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL86334A 1987-06-12 1988-05-11 Pharmaceutical compositions for transdermal delivery of a pure enantiomer IL86334A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6184287A	1987-06-12	1987-06-12

Publications (1)

Publication Number	Publication Date
IL86334A true IL86334A (en)	1992-09-06

Family

ID=22038497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL86334A IL86334A (en)	1987-06-12	1988-05-11	Pharmaceutical compositions for transdermal delivery of a pure enantiomer

Country Status (16)

Country	Link
EP (1)	EP0294601B1 (de)
JP (1)	JP2654092B2 (de)
KR (1)	KR970000506B1 (de)
AT (1)	ATE84714T1 (de)
AU (1)	AU609142B2 (de)
CA (1)	CA1305418C (de)
DE (1)	DE3877630T2 (de)
DK (1)	DK171746B1 (de)
ES (1)	ES2043719T3 (de)
GR (1)	GR3006938T3 (de)
IE (1)	IE62735B1 (de)
IL (1)	IL86334A (de)
NO (1)	NO178096C (de)
NZ (1)	NZ224891A (de)
PT (1)	PT87704B (de)
ZA (1)	ZA884186B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5045553A (en) *	1987-06-24	1991-09-03	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US5476854A (en) *	1991-11-27	1995-12-19	Sepracor Inc.	Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
US6075024A (en)	1991-11-27	2000-06-13	Sepracor Inc.	Methods for treating infection using optically pure (S)-lomefloxacin
US5834496A (en) *	1991-12-02	1998-11-10	Sepracor, Inc.	Methods for treating hypertension using optically pure S(-) felodipine
JPH08503465A (ja) *	1992-11-09	1996-04-16	ファーメトリックスコーポレイション	ケトロラックの経皮デリバリー
KR100988542B1 (ko)	2001-06-18	2010-10-20	노벤 파머수티컬즈, 인코퍼레이티드	경피 시스템에서의 강화된 약물 전달
EP1628663B1 (de)	2003-05-15	2009-07-29	Roskamp Research llc	Verfahren zur herstellung von medikamenten zur verringerung der amyloid-abscheidung, amyloid-neurotoxizität und mikrogliosis
NZ584729A (en)	2007-10-05	2012-12-21	Alzheimer S Inst Of America Inc	Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4338322A (en) *	1975-07-02	1982-07-06	Fujisawa Pharmaceutical Co., Ltd.	1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4284634A (en) *	1975-07-02	1981-08-18	Fujisawa Pharmaceutical Co., Ltd.	1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
CA1117117A (en) *	1978-10-10	1982-01-26	Fujisawa Pharmaceutical Co., Ltd.	2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPS6016917A (ja) *	1983-07-08	1985-01-28	Yamanouchi Pharmaceut Co Ltd	塩酸ニカルジピンまたはニフエジピンの軟膏剤
DE3419128A1 (de) *	1984-05-23	1985-11-28	Bayer Ag, 5090 Leverkusen	Dihydropyridinpraeparate und verfahren zu ihrer herstellung

1988
- 1988-05-10 EP EP88107473A patent/EP0294601B1/de not_active Expired - Lifetime
- 1988-05-10 AT AT88107473T patent/ATE84714T1/de not_active IP Right Cessation
- 1988-05-10 ES ES88107473T patent/ES2043719T3/es not_active Expired - Lifetime
- 1988-05-10 DE DE8888107473T patent/DE3877630T2/de not_active Expired - Lifetime
- 1988-05-11 IL IL86334A patent/IL86334A/xx not_active IP Right Cessation
- 1988-06-03 NZ NZ224891A patent/NZ224891A/en unknown
- 1988-06-09 PT PT87704A patent/PT87704B/pt not_active IP Right Cessation
- 1988-06-10 JP JP63141872A patent/JP2654092B2/ja not_active Expired - Fee Related
- 1988-06-10 IE IE174988A patent/IE62735B1/en not_active IP Right Cessation
- 1988-06-10 CA CA000569154A patent/CA1305418C/en not_active Expired - Lifetime
- 1988-06-10 NO NO882559A patent/NO178096C/no not_active IP Right Cessation
- 1988-06-10 DK DK316788A patent/DK171746B1/da not_active IP Right Cessation
- 1988-06-10 ZA ZA884186A patent/ZA884186B/xx unknown
- 1988-06-10 AU AU17610/88A patent/AU609142B2/en not_active Expired
- 1988-06-11 KR KR1019880007020A patent/KR970000506B1/ko not_active Expired - Fee Related
1993
- 1993-01-29 GR GR920402265T patent/GR3006938T3/el unknown

Also Published As

Publication number	Publication date
NZ224891A (en)	1992-06-25
IE62735B1 (en)	1995-02-22
NO178096C (no)	1996-01-24
EP0294601A3 (en)	1989-10-11
AU1761088A (en)	1988-12-15
PT87704A (pt)	1988-07-01
DE3877630D1 (de)	1993-03-04
ES2043719T3 (es)	1994-01-01
KR890000090A (ko)	1989-03-11
GR3006938T3 (de)	1993-06-30
JPS6413024A (en)	1989-01-17
AU609142B2 (en)	1991-04-26
DK316788D0 (da)	1988-06-10
DE3877630T2 (de)	1993-06-03
CA1305418C (en)	1992-07-21
DK171746B1 (da)	1997-05-05
NO882559D0 (no)	1988-06-10
ATE84714T1 (de)	1993-02-15
KR970000506B1 (ko)	1997-01-13
EP0294601A2 (de)	1988-12-14
NO178096B (no)	1995-10-16
IE881749L (en)	1988-12-12
EP0294601B1 (de)	1993-01-20
JP2654092B2 (ja)	1997-09-17
NO882559L (no)	1988-12-13
DK316788A (da)	1988-12-13
ZA884186B (en)	1989-03-29
PT87704B (pt)	1993-03-31

Legal Events

Date	Code	Title
1998-11-26	KB	Patent renewed
2002-06-30	KB	Patent renewed
2006-08-01	KB	Patent renewed
2008-12-29	EXP	Patent expired

Publication	Publication Date	Title
GR850507B (de)	1985-06-28
IL86334A (en)	1992-09-06	Pharmaceutical compositions for transdermal delivery of a pure enantiomer
AU1866888A (en)	1989-01-12	Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
EP0328634A4 (en)	1991-08-21	Pharmaceutical compositions for the treatment of psoriasis
HUT50787A (en)	1990-03-28	Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
IL105475A0 (en)	1993-08-18	Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
GR3001277T3 (en)	1992-08-26	Chlorpheniramine therapy
TW218011B (de)	1993-12-21
CS318690A3 (en)	1992-11-18	Pharmaceutical composition usable for depression therapy
ES523978A0 (es)	1984-04-16	Un metodo de prepara el enantiomero (+) s de secoverin
IL72726A0 (en)	1984-11-30	Crystalline salts of l or(s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters,their preparation and pharmaceutical compositions containing them
EP0429324A3 (en)	1992-05-27	Use of n-methyl-2-(3-pyridyl)2-tetrahydrothiopyran-carbothioamide-1-oxide for the preparation of medicaments for the treatment of coronary insufficiency
EP0315217A3 (de)	1991-02-27	Pharmazeutische Präparate